Toxicology

November 6, 2025

Deadly Multistate Listeria Outbreak Expands: A Wake-Up Call for Toxicologists and Product Developers

The CDC and FDA have confirmed a deadly multistate Listeria outbreak linked to ready-to-eat pasta meals, as reported by the Center for Infectious Disease Research and […]
November 5, 2025

The Black Box Nobody Reads – The FDA’s Strongest Warning, and Why It Matters

What Is a Black Box Warning? That bold black-bordered box on certain prescription labels — the one most people skip — is the FDA’s strongest safety warning, known as a Black Box Warning. It’s there to alert doctors and patients to serious or life-threatening risks, but it’s not a reason to panic. In fact, it’s a sign of transparency and accountability in the U.S. drug safety system
November 4, 2025

Blood Pressure Medication Recalled Over Carcinogen Levels: What This Means for Toxicology and Product Developers

The Recall That Shouldn’t Surprise Us Anymore When the FDA recalled certain batches of prazosin hydrochloride—a medication widely used for high blood pressure and PTSD—because of carcinogenic impurities, patients were understandably alarmed. But for toxicologists and product developers, this isn’t shocking.
October 27, 2025

FDA Recalls Cholesterol Medication — What Toxicology Can Teach Developers About Hidden Risks

When “Safe” Products Become a Safety Lesson The U.S. Food and Drug Administration (FDA) recently announced a recall of several cholesterol-lowering medications after routine testing detected nitrosamine impurities — chemicals that can increase cancer risk following long-term exposure. For patients, the immediate health risk is low. For scientists, regulators, and developers, however, this is a powerful reminder:
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.and Cookie policy
Read more
💬

Chat with us